Mercer Global Advisors Inc Horizon Therapeutics Public LTD CO Transaction History

Mercer Global Advisors Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$98.98 - $115.74 $88,587 - $103,587	895 Added 7.77%	12,410 $1.44 Million
Q2 2023 Aug 14, 2023	BUY	$96.34 - $112.38 $733,436 - $855,548	7,613 Added 195.11%	11,515 $1.18 Million
Q1 2023 May 15, 2023	BUY	$107.32 - $113.5 $149,926 - $158,559	1,397 Added 55.77%	3,902 $425,000
Q4 2022 Feb 08, 2023	BUY	$62.39 - $113.8 $156,286 - $285,069	2,505 New	2,505 $285,000
Q2 2022 Aug 10, 2022	SELL	$79.4 - $116.36 $43,114 - $63,183	-543 Reduced 17.47%	2,565 $205,000

Q1 2022 May 10, 2022	BUY	$86.42 - $109.81 $268,593 - $341,289	3,108 New	3,108 $327,000
Q4 2021 Feb 04, 2022	SELL	$98.56 - $119.91 $217,226 - $264,281	-2,204 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$91.91 - $110.37 $25,367 - $30,462	-276 Reduced 11.13%	2,204 $241,000
Q2 2021 Aug 10, 2021	SELL	$86.24 - $95.92 $241,989 - $269,151	-2,806 Reduced 53.08%	2,480 $232,000
Q1 2021 May 11, 2021	BUY	$71.83 - $95.48 $110,546 - $146,943	1,539 Added 41.07%	5,286 $487,000
Q4 2020 Feb 12, 2021	BUY	$67.0 - $84.39 $251,049 - $316,209	3,747 New	3,747 $274,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

Stay updated on Mercer Global Advisors Inc with notifications on news.